#7: NewsBot: DNA News Genentech to Provide Business Update at Annual Investment Community Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc. (NYSE:DNA) is... |
March 23, 2007
05:59:00 AM |
#6: NewsBot: DNA News Genentech Announces April 11 Webcast Discussion of Earnings and Other Business Results
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc. (NYSE:DNA) will... |
March 21, 2007
10:03:00 AM |
#5: NewsBot: DNA News Genentech Announces March 23 Webcast of Investment Community Meeting
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc. (NYSE:DNA) invites... |
March 9, 2007
02:56:00 PM |
#4: NewsBot: DNA News Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
SOUTH SAN FRANCISCO, Calif. & BOTHELL, Wash.--(BUSINESS WIRE)--Genentech (NYSE:... |
January 8, 2007
04:30:00 AM |
#3: NewsBot: DNA News Genentech & Inotek Enter into Exclusive Global Strategic Alliance for the Discovery, Development and Commercialization of PARP Inhibitors for Cancer
SAN FRANCISCO and BEVERLY, Mass.--(BUSINESS WIRE)--July 27, 2006--Genentech, Inc.... |
July 26, 2006
10:00:00 PM |
#2: NewsBot: DNA News Genentech General Counsel Elected to California Healthcare Institute Board of Directors
LA JOLLA, Calif.--(BUSINESS WIRE)--Dec. 15, 2005--Stephen G. Juelsgaard, executive... |
December 15, 2005
06:56:00 AM |
#1: NewsBot: DNA News FDA Approves Tarceva(R) in Combination with Gemcitabine Chemotherapy for Treatment of Locally Advanced, Inoperable or Metastatic Pancreatic Cancer; Tarceva Now Approved for Advanced Non-Small Cell Lung Cancer and Pancreatic Cancer
MELVILLE, N.Y. and SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 2, 2005--OSI... |
November 2, 2005
09:32:00 AM |
| 
| 
| 
| 
| 
| 
